Skip to the page

Data / Form D filings / Holobiome, Inc.

Holobiome, Inc.: Form D filings

Holobiome, Inc., a biotechnology company in Boston, MA, filed 4 Form D notices with the SEC between 2018 and 2026. The latest, on July 22, 2026, reports $10 million sold of a $10 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
650 ALBANY STREET STE 127, Boston, MA, 02118
Phone
(857) 244-1633
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1763027

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 22, 2026New notice$10,000,000$10,000,0005Dec 24, 2025sec.gov
Mar 20, 2024New notice$9,361,054$6,590,554$2,770,50019Mar 14, 2024sec.gov
Feb 11, 2021New notice$2,000,000$300,000$1,700,0002Feb 1, 2021sec.gov
Dec 28, 2018New notice$1,250,000$625,000$625,0001Dec 17, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Philip StrandwitzExecutive Officer, Director
Iain ChessellDirector
Joan LaRovereDirector
Michael LaFleurExecutive Officer

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Jul 20, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Holobiome, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.